HOPO Therapeutics is a clinical-stage pharmaceutical company developing best-in-class therapies for the prevention and treatment of heavy metal poisoning. Initial use cases include medical countermeasures against nuclear and radiological threats, and treatment of lead poisoning, a global unmet need affecting over one third of the world’s children.
We are located in Berkeley/Emeryville, CA